6.9 Million Euros Awarded to Three Progressive MS Symptom Studies
The International Progressive MS Alliance has selected three Phase II efficacy studies to receive EUR 6.9 million, testing telehealth pain management, brain-priming rehabilitation, and tailored exercise for people with progressive MS.